Index Performance
+2.23%
BMDB
+7.66%
TMLARGE
Overview
Description
Follow Biotechnology and pharma companies with a market cap between $30 million and $400 million.
- TickerBMDB
- Inception Date12/07/2023
- WeightingEqual
- # of holdings99
What's inside?
Holdings
All holdings as of July 26, 2024
CSV download
| Annovis Bio, Inc. (ANVS) | 1.63% | $116.97M | N/A | N/A | N/A |
| DiaMedica Therapeutics, Inc. (DMAC) | 1.49% | $157.72M | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA) | 1.40% | $310.20M | -18.74% | 63.29% | 2.30 |
| SIGA Technologies, Inc. (SIGA) | 1.39% | $711.94M | 205.54% | 87.32% | 2.99 |
| G1 Therapeutics, Inc. (GTHX) | 1.39% | $206.51M | 11.82% | 92.55% | 2.47 |
| IGM Biosciences, Inc. (IGMS) | 1.35% | $407.00M | -4.79% | -337.83% | 155.32 |
| Acumen Pharmaceuticals, Inc. (ABOS) | 1.33% | $204.87M | N/A | N/A | N/A |
| aTyr Pharma, Inc. (LIFE) | 1.32% | $153.89M | N/A | -227.66% | 99.16 |
| PDS Biotechnology Corp. (PDSB) | 1.30% | $144.52M | N/A | N/A | N/A |
| Neoleukin Therapeutics, Inc. (NLTX) | 1.28% | $576.56M | N/A | N/A | N/A |
| Solid Biosciences, Inc. (SLDB) | 1.27% | $347.33M | N/A | N/A | N/A |
| XBiotech, Inc. (XBIT) | 1.24% | $213.81M | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO) | 1.24% | $283.72M | -100.00% | N/A | 322.28 |
| Sutro Biopharma, Inc. (STRO) | 1.23% | $350.49M | 2.64% | 86.46% | 1.42 |
| ADC Therapeutics SA (ADCT) | 1.21% | $367.58M | -4.94% | 81.43% | 3.80 |
| Ocular Therapeutix, Inc. (OCUL) | 1.19% | $1.28B | 10.47% | 91.02% | 13.25 |
| InspireMD, Inc. (NSPR) | 1.19% | $74.38M | 21.95% | 19.32% | 7.51 |
| CARA Therapeutics, Inc. (CARA) | 1.19% | $19.96M | -65.37% | 68.99% | 1.50 |
| Axogen, Inc. (AXGN) | 1.17% | $407.76M | 12.86% | 78.83% | 2.41 |
| Immunic, Inc. (IMUX) | 1.15% | $125.21M | N/A | N/A | N/A |
| Ocuphire Pharma, Inc. (OCUP) | 1.15% | $52.89M | -2.17% | N/A | 0.11 |
| Relmada Therapeutics, Inc. (RLMD) | 1.14% | $122.21M | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 1.14% | $842.28M | 4,608.33% | 84.51% | 146.95 |
| Mind Medicine (MindMed), Inc. (MNMD) | 1.13% | $678.95M | N/A | N/A | N/A |
| Astria Therapeutics, Inc. (ATXS) | 1.12% | $656.21M | N/A | N/A | N/A |
| KalVista Pharmaceuticals, Inc. (KALV) | 1.11% | $614.97M | N/A | N/A | N/A |
| Annexon, Inc. (ANNX) | 1.11% | $650.93M | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX) | 1.10% | $84.12M | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA) | 1.09% | $47.87M | 2,131.40% | 92.74% | 4.14 |
| Ocugen, Inc. (OCGN) | 1.09% | $419.49M | N/A | 82.35% | 166.04 |
| Kodiak Sciences, Inc. (KOD) | 1.09% | $169.16M | N/A | N/A | N/A |
| Adverum Biotechnologies, Inc. (ADVM) | 1.07% | $167.92M | -100.00% | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX) | 1.07% | $92.50M | -100.00% | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI) | 1.06% | $223.28M | N/A | N/A | N/A |
| Aldeyra Therapeutics, Inc. (ALDX) | 1.05% | $243.01M | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE) | 1.05% | $233.60M | 25.23% | 73.62% | 5.61 |
| Nektar Therapeutics (NKTR) | 1.05% | $252.11M | 0.21% | 60.56% | 1.38 |
| Larimar Therapeutics, Inc. (LRMR) | 1.03% | $601.02M | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX) | 1.03% | $110.65M | 76.45% | 98.87% | 0.36 |
| Carisma Therapeutics, Inc. (SESN) | 1.02% | $44.87M | 4.75% | 50.16% | 2.91 |
| Galecto, Inc. (GLTO) | 1.02% | $15.19M | N/A | N/A | N/A |
| VYNE Therapeutics, Inc. (VYNE) | 1.01% | $30.51M | -1.01% | N/A | 106.15 |
| Voyager Therapeutics, Inc. (VYGR) | 1.01% | $499.88M | -87.03% | 93.87% | 1.51 |
| Leap Therapeutics, Inc. (LPTX) | 1.01% | $83.03M | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR) | 1.01% | $328.47M | N/A | N/A | N/A |
| Cidara Therapeutics, Inc. (CDTX) | 1.01% | $84.11M | -67.44% | 81.53% | 1.27 |
| Lyra Therapeutics, Inc. (LYRA) | 1.00% | $18.84M | 29.76% | 74.44% | 207.67 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 1.00% | $191.39M | 13.29% | 93.14% | 2.25 |
| Oramed Pharmaceuticals, Inc. (ORMP) | 1.00% | $103.20M | -100.00% | N/A | -34.99 |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.98% | $161.44M | -100.00% | N/A | 23.19 |
| Abeona Therapeutics, Inc. (ABEO) | 0.98% | $206.04M | N/A | N/A | 45.29 |
| Esperion Therapeutics, Inc. (ESPR) | 0.97% | $460.39M | 466.14% | 92.69% | 3.61 |
| ProQR Therapeutics NV (PRQR) | 0.97% | $153.93M | 587.25% | 84.47% | 8.51 |
| VistaGen Therapeutics, Inc. (VTGN) | 0.97% | $98.48M | N/A | 46.62% | -13.96 |
| Galectin Therapeutics, Inc. (GALT) | 0.97% | $158.48M | N/A | N/A | N/A |
| Precigen, Inc. (PGEN) | 0.96% | $419.02M | -42.46% | -76.10% | 59.44 |
| ESSA Pharma, Inc. (EPIX) | 0.96% | $240.45M | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX) | 0.96% | $78.77M | 21.50% | N/A | 0.04 |
| Delcath Systems, Inc. (DCTH) | 0.95% | $241.74M | 425.80% | 71.23% | 21.71 |
| Precision BioSciences, Inc. (DTIL) | 0.95% | $70.43M | 100.27% | 91.88% | -0.66 |
| Actinium Pharmaceuticals, Inc. (ATNM) | 0.94% | $235.29M | N/A | N/A | 1,682.42 |
| AlloVir, Inc. (ALVR) | 0.93% | $86.93M | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO) | 0.92% | $76.39M | 468.11% | N/A | 0.15 |
| PMV Pharmaceuticals, Inc. (PMVP) | 0.92% | $84.88M | N/A | N/A | N/A |
| CorMedix, Inc. (CRMD) | 0.91% | $258.86M | N/A | N/A | N/A |
| Exagen, Inc. (XGN) | 0.91% | $35.27M | 28.36% | 59.65% | 0.44 |
| Accelerate Diagnostics, Inc. (AXDX) | 0.90% | $27.12M | 3.88% | 24.75% | 3.59 |
| ReWalk Robotics Ltd. (RWLK) | 0.89% | $32.95M | 329.51% | 16.94% | 1.44 |
| Vanda Pharmaceuticals, Inc. (VNDA) | 0.89% | $357.92M | -24.06% | 88.50% | -0.83 |
| BioVie, Inc. (BIVI) | 0.88% | $27.07M | N/A | N/A | N/A |
| Vivani Medical, Inc. (EYES) | 0.88% | $68.72M | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV) | 0.88% | $29.01M | N/A | N/A | N/A |
| Chimerix, Inc. (CMRX) | 0.88% | $79.35M | -100.00% | N/A | -1,530.42 |
| Kineta, Inc. (YMTX) | 0.88% | $8.33M | -100.00% | N/A | 1.05 |
| Karyopharm Therapeutics, Inc. (KPTI) | 0.88% | $119.67M | -14.40% | 93.97% | 1.44 |
| InflaRx NV (IFRX) | 0.88% | $90.09M | N/A | -511.93% | 11.55 |
| Achieve Life Sciences, Inc. (ACHV) | 0.87% | $167.93M | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN) | 0.87% | $53.61M | -77.37% | -741.84% | 3.84 |
| Mersana Therapeutics, Inc. (MRSN) | 0.87% | $242.28M | 18.50% | 95.42% | 10.29 |
| SOPHiA GENETICS SA (SOPH) | 0.87% | $302.69M | 12.98% | 65.94% | 3.67 |
| Verrica Pharmaceuticals, Inc. (VRCA) | 0.86% | $307.55M | 10,240.54% | 70.26% | 30.59 |
| IRIDEX Corp. (IRIX) | 0.85% | $32.34M | -14.19% | 37.19% | 0.91 |
| AC Immune SA (ACIU) | 0.85% | $387.86M | N/A | N/A | 10.88 |
| electroCore, Inc. (ECOR) | 0.85% | $38.80M | 95.79% | 83.69% | 1.84 |
| SELLAS Life Sciences Group, Inc. (SLS) | 0.85% | $67.00M | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB) | 0.84% | $91.50M | N/A | 99.45% | -2.94 |
| Cardiff Oncology, Inc. (CRDF) | 0.84% | $105.77M | 146.99% | 50.24% | 284.25 |
| MediciNova, Inc. (MNOV) | 0.83% | $63.76M | N/A | N/A | 24.55 |
| GlycoMimetics, Inc. (GLYC) | 0.83% | $15.16M | N/A | N/A | 16,272.10 |
| Verastem, Inc. (VSTM) | 0.83% | $75.22M | N/A | N/A | N/A |
| Aadi Bioscience, Inc. (AADI) | 0.83% | $39.53M | -8.76% | 87.82% | -0.76 |
| Minerva Neurosciences, Inc. (NERV) | 0.79% | $21.82M | N/A | N/A | N/A |
| Immuneering Corp. (IMRX) | 0.77% | $36.47M | N/A | N/A | N/A |
| Tempest Therapeutics, Inc. (TPST) | 0.74% | $38.21M | N/A | N/A | N/A |
| Allakos, Inc. (ALLK) | 0.73% | $76.59M | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB) | 0.71% | $84.78M | N/A | N/A | N/A |
| Curis, Inc. (CRIS) | 0.68% | $35.48M | -9.19% | 77.71% | 6.60 |
| Daré Bioscience, Inc. (DARE) | 0.61% | $30.33M | N/A | -15.87% | 18.25 |
| Sol-Gel Technologies Ltd. (SLGL) | 0.53% | $12.53M | -38.52% | N/A | -2.44 |
Market data by FactSet